Herein, we reported two novel serum biomarkers, CCL20 (C-C motif chemokine ligand 20) and LCN2 (lipocalin 2), which were selected as biomarkers on the ground of mining data from the HCC gene expression array. This evidence concerns the gene LCN2 and hepatocellular carcinoma.